1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Zn-Telomir: new trials by email Literature Review of Zn-Telomir trials Research Report on Zn-Telomir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) Zn-Telomir - Triple-Negative Breast Cancer (TNBC), Advanced Triple-Negative Breast Cancer | Phase 1 / Phase 2 | Not yet recruiting | Telomir Pharmaceuticals, Inc. | 76 | 2026-10-01 | 2026-06-23 |
Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)